PCM
QGENF

Prelude Capital Management’s QIAGEN NV QGENF Stock Holding History

Prelude Capital Management’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-8,200
Closed -$182K – 2119
2015
Q2 		$182K Buy
+8,200
New +$182K 0.03% 656

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Prelude Capital Management's QGENF Position: Q1 2017 in Review

Prelude Capital Management sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 4,361 shares — an estimated $122K sold.

Prelude Capital Management first reported a position in QGENF in Q2 2013 and held it in 8 quarters. The position peaked at $1.05M in Q2 2013. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Prelude Capital Management reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Prelude Capital Management sold 4,361 QIAGEN NV shares in Q1 2017, an estimated $122K.
  • Prelude Capital Management first reported a position in QIAGEN NV in Q2 2013 and held it in 8 quarters.
  • Prelude Capital Management's QIAGEN NV position peaked at $1.05M in Q2 2013.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Prelude Capital Management's 13F filing for Q1 2017, filed 15 May 2017.